Skye Bioscience Inc
NASDAQ:SKYE

Watchlist Manager
Skye Bioscience Inc Logo
Skye Bioscience Inc
NASDAQ:SKYE
Watchlist
Price: 2.7 USD -5.59% Market Closed
Market Cap: 81.9m USD
Have any thoughts about
Skye Bioscience Inc?
Write Note

Cash Flow Statement

Cash Flow Statement
Skye Bioscience Inc

Rotate your device to view
Cash Flow Statement
Currency: USD
Sep-2014 Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024
Operating Cash Flow
Net Income
(1)
(3)
(4)
(6)
(6)
(5)
(6)
(3)
(3)
(3)
(3)
(4)
(4)
(3)
(10)
(12)
(14)
(19)
(26)
(7)
(10)
1
13
(4)
(0)
(7)
(6)
(7)
(8)
(9)
(9)
(11)
(12)
(19)
(22)
(21)
(43)
(38)
(37)
(42)
(21)
Depreciation & Amortization
0
0
0
(0)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Stock-Based Compensation
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
0
0
0
0
0
1
1
1
1
1
1
1
1
1
1
3
5
0
Other Non-Cash Items
0
0
1
2
2
2
2
(1)
(1)
(0)
(1)
1
1
0
7
8
10
15
21
2
4
(7)
(21)
(3)
(6)
0
1
1
1
1
1
1
1
7
9
9
30
24
24
26
2
Cash Taxes Paid
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(0)
0
0
Cash Interest Paid
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Change in Working Capital
0
1
0
1
0
(0)
(1)
(1)
(0)
0
0
1
1
(0)
(0)
(1)
(1)
0
(0)
0
0
0
1
1
1
0
(1)
(1)
(0)
1
0
0
1
(1)
(1)
(1)
(2)
(0)
(1)
(4)
(2)
Cash from Operating Activities
(1)
N/A
(2)
-85%
(3)
-43%
(3)
-23%
(3)
-11%
(4)
-9%
(4)
-11%
(5)
-16%
(4)
+16%
(4)
+11%
(3)
+9%
(2)
+30%
(2)
+18%
(3)
-80%
(4)
-6%
(4)
-22%
(5)
-17%
(4)
+22%
(4)
-10%
(5)
-13%
(6)
-14%
(6)
-9%
(6)
+3%
(5)
+10%
(6)
-9%
(6)
-5%
(6)
-1%
(7)
-11%
(6)
+7%
(6)
-3%
(8)
-24%
(9)
-15%
(10)
-6%
(13)
-30%
(14)
-9%
(13)
+7%
(15)
-15%
(14)
+7%
(15)
-5%
(20)
-35%
(21)
-6%
Investing Cash Flow
Capital Expenditures
(0)
(0)
(0)
0
(0)
0
(0)
(0)
(0)
(0)
0
0
0
(0)
(0)
(0)
(0)
0
0
0
0
0
0
0
0
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(1)
(0)
(0)
0
0
(0)
(0)
(0)
(2)
Other Items
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5
11
11
12
7
2
2
1
Cash from Investing Activities
(0)
N/A
(0)
-100%
(0)
N/A
0
N/A
(0)
N/A
0
N/A
(0)
N/A
(0)
N/A
(0)
N/A
(0)
N/A
0
N/A
0
N/A
0
N/A
(0)
N/A
(0)
N/A
(0)
N/A
(0)
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
(0)
N/A
(0)
-100%
(0)
N/A
(0)
-150%
(0)
-80%
(0)
+11%
(0)
-113%
(1)
-194%
5
N/A
11
+106%
11
+1%
12
+13%
7
-46%
2
-67%
2
-1%
(0)
N/A
Financing Cash Flow
Net Issuance of Common Stock
2
2
3
4
7
7
6
5
(0)
0
2
2
2
3
5
5
5
3
(0)
(0)
(0)
6
0
0
12
6
10
12
13
13
9
7
(0)
0
0
0
12
12
97
95
84
Net Issuance of Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
2
6
6
6
0
(4)
(3)
(3)
1
0
0
0
0
0
0
0
(0)
(0)
(0)
5
5
5
5
(0)
Other
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(0)
(0)
(0)
0
0
0
(0)
(0)
0
0
0
Cash from Financing Activities
2
N/A
2
N/A
3
+36%
4
+35%
7
+85%
7
0%
6
-11%
5
-16%
(0)
N/A
0
N/A
2
+276%
2
N/A
2
N/A
4
+128%
6
+74%
6
0%
6
N/A
6
-9%
6
+5%
6
+0%
6
N/A
6
+3%
2
-67%
3
+28%
9
+236%
7
-23%
11
+60%
12
+11%
13
+11%
13
-1%
9
-31%
7
-20%
(0)
N/A
(0)
+34%
(0)
+5%
(0)
-15%
17
N/A
16
0%
102
+521%
100
-2%
84
-17%
Change in Cash
Net Change in Cash
1
N/A
0
-80%
0
-14%
1
+239%
3
+444%
3
-9%
2
-38%
0
-88%
(4)
N/A
(3)
+22%
(2)
+47%
(1)
+57%
(0)
+57%
0
N/A
3
+1 506%
2
-31%
1
-41%
2
+52%
1
-8%
1
-37%
0
-71%
(0)
N/A
(4)
-12 733%
(3)
+30%
3
N/A
1
-78%
5
+617%
5
+11%
7
+35%
7
-5%
1
-87%
(2)
N/A
(11)
-371%
(8)
+27%
(3)
+57%
(2)
+29%
14
N/A
9
-34%
90
+888%
83
-8%
62
-25%
Free Cash Flow
Free Cash Flow
(1)
N/A
(2)
-85%
(3)
-42%
(3)
-20%
(3)
-13%
(4)
-9%
(4)
-11%
(5)
-16%
(4)
+16%
(4)
+11%
(3)
+10%
(2)
+30%
(2)
+18%
(3)
-81%
(4)
-6%
(4)
-22%
(5)
-17%
(4)
+22%
(4)
-10%
(5)
-13%
(6)
-14%
(6)
-9%
(6)
+3%
(5)
+10%
(6)
-9%
(6)
-5%
(6)
-1%
(7)
-11%
(6)
+7%
(7)
-3%
(8)
-24%
(9)
-16%
(10)
-9%
(13)
-24%
(14)
-9%
(13)
+7%
(15)
-13%
(14)
+5%
(15)
-5%
(20)
-35%
(22)
-14%

See Also

Discover More